ADAM9 Human shRNA Lentiviral Particle (Locus ID 8754)
CAT#: TL314947V
ADAM9 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
货期*
详询
规格
Cited in 2 publications. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | ADAM9 Human shRNA Lentiviral Particle (Locus ID 8754) |
Locus ID | 8754 |
Synonyms | KIAA0021; MCMP; MDC9; Mltng |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | BC027996, NM_001005845, NM_003816, NR_027638, NR_027639, NR_027878, NM_003816.1, NM_003816.2, NM_001005845.1, BC126406, BC143923, BC143924, NM_003816.3 |
Summary | This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Analysis of ADAM9 Regulation and Function in Vestibular Schwannoma Primary Cells
,Nattmann, A;Breun, M;Monoranu, C;Matthies, C;Ernestus, R;Löhr, M;Hagemann, C;,
Research Square
[ADAM9]
|
Platelet integrin α6 β1 controls lung metastasis through direct binding to cancer cell–derived ADAM9
,null,
JCI Insight
,PubMed ID 27699237
[ADAM9]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...